Mustang Bio, Inc.
MBIO
$1.16
-$0.04-3.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.34M | -3.28M | -10.71M | -15.75M | -23.42M |
| Total Depreciation and Amortization | 116.00K | 167.00K | 168.00K | 823.00K | 1.11M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | 825.00K | 639.00K | 2.59M | 2.81M | 1.82M |
| Change in Net Operating Assets | -4.15M | -4.01M | 478.00K | 713.00K | 3.82M |
| Cash from Operations | -5.54M | -6.48M | -7.48M | -11.41M | -16.67M |
| Capital Expenditure | -- | -- | -- | -- | -30.00K |
| Sale of Property, Plant, and Equipment | 1.17M | 1.17M | 1.17M | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | 1.17M | 1.17M | 1.17M | -- | -30.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 20.32M | 14.19M | 19.46M | 11.89M | 10.73M |
| Repurchase of Common Stock | -235.00K | -235.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -626.00K | -626.00K | -626.00K | -626.00K | -442.00K |
| Cash from Financing | 19.46M | 13.33M | 18.83M | 11.27M | 10.29M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.08M | 8.01M | 12.52M | -145.00K | -6.41M |